CRWV stock is down 38% from its 52-week high because AI infrastructure names have been hit by heavy insider selling and profit-taking after a historic run — but 39 analysts still rate CoreWeave a Buy with a $127 average price target.
That gap between price and price target is the reason CoreWeave deserves a closer look right now. The stock touched $187 in late 2025 on the back of 168% annual revenue growth, then gave back more than a third of its value in the first four months of 2026 as Magnetar Financial unloaded $50 million of shares, CEO Mike Intrator trimmed his holdings, and co-founder Brannin McBee sold another $11 million on April 13. At the same time, Cantor Fitzgerald pushed its target to $156 on the back of a freshly-announced $6 billion Jane Street compute deal, and both Evercore ISI and Wolfe Research now sit at $150. That is the classic shape of a setup where the risk/reward favours bulls — price weak, fundamentals accelerating, coverage expanding. Below, we break down exactly what is pulling CRWV lower, what Wall Street sees on the other side of the selloff, and whether the 38% drawdown is a gift or a warning.
Table of Contents
- Key Stock Data
- Recent Stock Performance
- Why Is CRWV Down Today?
- CoreWeave Business Overview
- Bullish and Bearish Analyst Opinions on CoreWeave
- CoreWeave Financial Performance
- CRWV Stock Forecast and Price Targets for 2026
- Technical Analysis: Support and Resistance Levels
- How to Trade CRWV via MEXC
- Frequently Asked Questions
- Final Verdict
Key Stock Data
| Metric | Value |
|---|---|
| Price | $116.47 |
| 52-Week Range | $33.52 – $187.00 |
| Market Cap | $62.8 billion |
| P/E Ratio | N/A (unprofitable) |
| EPS (TTM) | -$0.56 |
| Analyst Consensus | Buy (39 analysts) |
| Average Price Target | $127.00 |
| High Target / Low Target | $156 / $106 |
CoreWeave trades at roughly 12 times trailing revenue, a premium multiple that only makes sense if you believe the 168% 2025 growth rate compounds into something durable. The company is not yet GAAP profitable — full-year 2025 delivered a net loss, with Q4 EPS of negative $0.56 beating the negative $0.65 analysts expected. The 52-week range tells the whole story: a $33.52 low right after the IPO, a $187 high in late 2025, and a 38% retracement from that peak.
Recent Stock Performance
CRWV began life on the public market in March 2025 at a $40 IPO price and promptly traded lower, bottoming near $33.52 in its first weeks. From there the stock went on one of the most spectacular runs of the year, rallying nearly 465% to $187 by December 2025 as AI hyperscaler capacity demand outpaced every revenue forecast on the sell side. That parabolic move is the single biggest reason for the 2026 weakness — shareholders who bought at $40, $60, or even $100 are sitting on enormous gains and have every incentive to trim.
Over the trailing 52 weeks the stock is still up roughly 191%, a figure that dwarfs Nasdaq, the S&P 500, and virtually every peer in the AI infrastructure space. The last 30 days tell a different story — shares are down mid-single digits, and the last session closed 2.3% lower at $116.85 on heavy volume. Volatility is elevated. CRWV routinely moves 3-5% on a normal trading day, and single-day swings of 8-10% are common around earnings and customer announcements.
Why Is CRWV Down Today?
The short answer is profit-taking plus insider supply. The longer answer breaks into five overlapping catalysts.
First, insider selling has been relentless. Co-founder Brannin McBee sold 100,000 shares on April 13 at an average price of $110.81, a roughly $11 million transaction. CEO Mike Intrator has also trimmed, his direct holdings stepping down 3.66% to 5,266,501 shares. On top of that, early investor Magnetar Financial disclosed a $50.1 million sale. These are not distress sales — they are concentrated, calendar-driven distributions — but the market reads them as a signal that people closest to the company are locking in gains.
Second, valuation discipline is catching up. CoreWeave trades at a double-digit revenue multiple on a company that is still burning cash to expand capacity. Every 25 basis points of risk-free rate, every rotation out of long-duration growth, and every quarter of negative earnings makes the multiple harder to defend — even with triple-digit growth.
Third, concentration risk is real. Microsoft remains the single largest customer, and any whisper about its data-center spend directly pulls CRWV with it. The stock dropped several percent on early-April headlines questioning hyperscaler capex cadence before reclaiming some ground later in the month.
Fourth, competitive pressure has intensified. Oracle ramped its OCI AI capacity, Nvidia expanded DGX Cloud, and legacy clouds from Amazon and Microsoft each announced new GPU allocation programs. None of this erases the CoreWeave moat — it is still the largest dedicated GPU-cloud — but it compresses the narrative premium.
Fifth, the tape itself did the rest. AI infrastructure was the leadership group of 2025, and when leadership groups correct, they correct hard. Peers like Nebius and Vertiv have also seen 15-25% drawdowns in the same window.
CoreWeave Business Overview
CoreWeave is a specialised cloud provider built around Nvidia GPUs for AI training and inference workloads. Founded in 2017 as a cryptocurrency mining operator, the company pivoted to AI compute in 2019 and now operates more than 30 data centres with more than 250,000 Nvidia GPUs deployed or contracted. Key customers include Microsoft (estimated 40-50% of revenue), OpenAI via the Stargate framework, IBM, and a lengthening list of enterprise and research clients.
The April 2026 Jane Street announcement materially shifts the customer mix. Jane Street will deploy across multiple CoreWeave facilities under a six-year framework valued at roughly $6 billion, and will separately invest $1 billion at $109 per share. That second leg is doubly interesting — it is both a capital injection and a very public floor under the stock set by a firm not known for bad pricing.
The core bull thesis is that GPU demand runs well ahead of supply through at least 2027, that Nvidia’s Blackwell and subsequent roadmap keeps CoreWeave’s installed base commercially relevant, and that the company can translate contracted backlog into free cash flow as the data-centre buildout curve bends.
Bullish and Bearish Analyst Opinions on CoreWeave
Coverage has expanded rapidly since the IPO. As of April 2026, 32 active analysts rate the stock, with the house view firmly in the Buy camp but a non-trivial minority urging caution on valuation.
| Reasons for the Decline | Reasons the Drop Is Overdone |
|---|---|
| Insider selling above $100 signals supply | Jane Street’s $1B primary investment at $109 sets a de facto floor |
| Double-digit price-to-revenue multiple is hard to defend without earnings | $6B Jane Street compute deal extends revenue visibility into 2030 |
| Microsoft customer concentration creates headline risk | 168% 2025 revenue growth with 2026 guide of $1.9-2.0B in Q1 alone |
| Competitive pressure from OCI, AWS, and Azure GPU allocations | 39 analysts still rate the stock Buy with $127 average target |
| Cash burn continues as capex outpaces operating cash flow | Cantor, Evercore ISI, and Wolfe all sit at $150-156 targets |
On the bullish side, Cantor Fitzgerald’s $156 target is the highest on the street, explicitly citing the Jane Street transaction as a validating data point. Evercore ISI moved to $150 shortly after. Wolfe Research initiated at $150 with an Outperform, framing CRWV as the purest public-market expression of the AI compute build-out. Bank of America, JPMorgan, Citi, and Morgan Stanley all carry Buy-equivalent ratings in the $125-145 band.
On the bearish side, Barclays sits at $106 — below the current quote — flagging customer concentration and near-term margin compression as capex cycles peak. A small cluster of Hold-rated firms express similar reservations: the story is compelling, but the entry price after a 465% IPO-to-peak run leaves limited margin for execution error.
CoreWeave Financial Performance
CoreWeave reported Q4 2025 revenue of $1.6 billion, up 110% year-over-year, rounding out a full-year 2025 revenue print of $5.1 billion — a 168% increase over 2024. Adjusted operating income swung positive on an annual basis, though GAAP net income remained in the red as depreciation on rapidly-expanding capacity and interest on project-level debt both ballooned. Q4 EPS of negative $0.56 beat the negative $0.65 consensus.
Guidance for Q1 2026 calls for $1.9-2.0 billion in revenue and adjusted operating income of $0-40 million. On the high end of that revenue band, Q1 alone would generate almost 40% of what the company produced in all of 2025 — a useful calibration for just how steep the ramp is. The company’s remaining performance obligation (RPO), which captures contracted but unrecognised revenue, is widely reported above $15 billion, which is why analyst models continue to push 2027 and 2028 estimates higher even as the share price corrects.
Capital intensity is the other side of this coin. CoreWeave is spending aggressively on data-centre buildout, GPU procurement, and power-contracted capacity. Free cash flow remains negative as a result. Investors willing to underwrite CoreWeave need conviction that those invested dollars compound into long-duration, multi-year cash generation — and that the capex cycle normalises before leverage becomes a concern.
CRWV Stock Forecast and Price Targets for 2026
The CRWV stock price currently sits 8.5% below the $127 consensus target and more than 30% below the $156 bull-case target. Roughly three-quarters of the 39 covering analysts have buy-equivalent ratings, with another 20% at Hold and a small cluster at Sell.
The bull case looks like this: CoreWeave delivers on $1.9-2.0 billion of Q1 2026 revenue, reaffirms a full-year trajectory of $9-10 billion, and converts contracted backlog into positive free cash flow by late 2026. If that playbook executes, the stock retraces the $187 high and pushes toward $150-160 on a 12-month horizon.
The bear case centres on customer concentration, capex overhang, and multiple compression. If Microsoft moderates its 2026 GPU purchases, if interest expense on project-level financing climbs faster than operating cash flow, or if competitive pricing in the GPU-cloud market compresses realised rates, CRWV could see another leg lower into the $90-100 zone. Barclays’ $106 target effectively prices that outcome.
The base case — which is where most sell-side models cluster — has CRWV revisiting $130-135 over the next two quarters as Q1 earnings confirm the guide and the Jane Street capital hits the balance sheet. For investors with a two- to three-year horizon and tolerance for 20-30% drawdowns along the way, the current setup is compelling at current levels.
Technical Analysis: Support and Resistance Levels
From a technical standpoint, CRWV is in a textbook retracement after a parabolic advance. The 200-day moving average sits near $108, and the $109 Jane Street primary-investment price provides an unusually clean technical reference — large institutions put $1 billion to work at that level, which tends to create a psychological floor. Below that, the next area of prior support is $95-98, where the stock consolidated in October 2025.
To the upside, the first resistance is the recent $125-127 supply zone, which aligns neatly with consensus. A close above that opens the door to the $145-150 area where several sell-side targets cluster. The $187 52-week high is the final ceiling, and reclaiming it would require either multiple expansion on resolved capex concerns or an acceleration in revenue beyond the current guide.
RSI has reset from overbought levels above 80 in late 2025 to the low 40s, removing the technical overhang that prompted the March-April distribution. Volume profile shows the heaviest trade concentration in the $100-115 band, consistent with the idea that the market is building a new cost basis around current prices.
How to Trade CRWV via MEXC
For traders who want exposure outside the U.S. equity session, MEXC lists CoreWeave as a tokenised stock at the CRWV USDT exchange. CRWVON_USDT trades 24/7, settles in USDT, and can be opened without a U.S. brokerage account or traditional market-hours restriction. For investors in jurisdictions where direct access to U.S. equities is cumbersome, or for anyone who wants to react to post-market news flow — insider filings, customer wins, macro prints — tokenised exposure is a practical bridge to the same underlying asset.
Keep in mind that tokenised stocks track the reference equity but are not identical instruments. Liquidity, spread, and overnight funding mechanics differ from a cash equity. Position sizing should reflect that, especially during U.S. market holidays when the underlying does not trade but CRWVON continues to move on Asian and European order flow.
Before entering any crwv stock price analysis driven trade, confirm that the tokenised instrument is supported in your region and size according to your own risk framework.
Frequently Asked Questions
Why is CRWV stock dropping?
CRWV is down 38% from its December 2025 high primarily because of profit-taking after a 465% IPO-to-peak rally, accelerated by insider selling from the CEO, co-founder, and early investor Magnetar Financial. Layer on customer-concentration concerns around Microsoft and valuation discipline returning to AI infrastructure names, and you get the textbook anatomy of a post-parabolic correction. Fundamentals are still accelerating — the problem is price, not business.
Is CRWV a buy after the drop?
The honest answer is that it depends on your time horizon and tolerance for volatility. Over a 12- to 24-month window, the $109 Jane Street primary-investment price looks like a well-defined floor, the $127 analyst consensus offers 8-9% upside, and the $156 Cantor target implies roughly 34% upside from current levels. The risk is another 10-15% leg lower if Q1 results disappoint or if the Fed pushes back on rate cuts. For investors willing to accept that risk, the setup is compelling at current levels.
Will CRWV stock recover?
Recovery is more likely than not, but the timing is data-dependent. The May 20, 2026 earnings print is the next major catalyst. If CoreWeave confirms its $1.9-2.0 billion Q1 revenue guide and speaks confidently about 2026 free cash flow trajectory, the stock should reclaim $130-135 quickly. A miss on either line pushes the recovery into the second half of 2026.
What are bullish and bearish analyst opinions on CoreWeave?
Bulls — led by Cantor at $156 and Evercore ISI and Wolfe at $150 — point to the $6 billion Jane Street deal, $15 billion+ contracted backlog, and 168% 2025 revenue growth. Bears — Barclays at $106 — flag Microsoft concentration, capex intensity, and multiple compression on a still-unprofitable company. The consensus reads as a 39-analyst Buy with a $127 average target.
How does CoreWeave make money?
CoreWeave rents Nvidia GPU capacity to enterprise, hyperscaler, and research customers on multi-year contracts. Revenue is primarily recurring, capacity-based, and tied to specific GPU SKUs (H100, H200, and increasingly Blackwell). The company monetises through both raw compute rental and higher-level managed services for AI training and inference.
Is CoreWeave profitable?
Not yet on a GAAP basis. CoreWeave posted Q4 2025 EPS of negative $0.56 and full-year 2025 net loss, though adjusted operating income was positive. Management’s framing is that 2026-2027 is the window for GAAP profitability as capex normalises and depreciation stabilises relative to revenue.
Final Verdict
CRWV at $116 is not the low-risk entry that $40 or $60 was in 2025. It is, however, a stock where insider supply has been absorbed, a $1 billion primary investment sets a visible floor, and 39 analysts still point to upside of 8-34% depending on which target you weight most heavily. The 38% drawdown from $187 is the market doing what markets always do after a parabolic move — reclaim the froth. What it has not done is change the underlying revenue trajectory, which is still running at 100%+ year-over-year.
For aggressive investors with a multi-year horizon, current levels offer a rare entry into a leading AI infrastructure name at a meaningful discount to peak sentiment. For more conservative investors, waiting for either the May 20 earnings print or a decisive reclaim of the $127 consensus level is a defensible call. Either way, the story is nowhere near over — the question is simply how much drawdown you will tolerate to be part of it.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.